Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559
For more info: http://rltr.realpennies.com
REELTIME RENTALS INCORPORATED (OTC: RLTR) up 5.41% in morning trading
ReelTime Rentals Inc. (sometimes referred to herein as RLTR or ReelTime.com) was incorporated under the corporate laws of the state of Washington as ReelTime Rentals; Inc on June 24, 2004. ReelTime.com is an online broadband network offering a diverse library of both theatrical films and television programming. ReelTime's "point click and watch" user interface delivers DVD quality video over the internet to customers nationwide whenever they want to see it. ReelTime is poised to change the home entertainment industry by becoming a leader in the online media marketplace, providing the public the next generation of online viewing technology with built-in capacity for unlimited growth. The company's Intelligent Rapid Delivery System (IRDS) overcomes many of the roadblocks that have previously prevented widespread adoption of high quality streaming video. Through IRDS and their video-on-demand services, they deliver full-screen DVD quality movie experiences to broadband customers nationwide while implementing security measures to combat the threat of piracy.
The company currently provides direct-to-desktop progressive downloading for broadband users, utilizing a proprietary player to deliver full length films and television shows for viewing by the next generation of media viewers. We strongly believe in ReelTimes future and see unlimited potential beyond the PC into other media platforms, including set top boxes and handheld devices. ReelTime's end-to-end delivery system (IRDS) has significant advantages in cost and structure over other systems in current use and the revolutionary nature of the system should allow ReelTime to quickly become a dominant player in the video-on-demand marketplace.
RLTR News:
February 20 - ReelTime Announces Open Conference Call to Discuss New Marketing Joint Venture
ReelTime Rentals, Inc. (OTC: RLTR) announced that the Company will hold a public conference call Thursday, February 28th at 10:00AM PST, 1:00PM EST.
Barry Henthorn, CEO, remarked, "ReelTime is making huge strides with our latest marketing partnership. The new venture, which puts ReelTime on the shelves of several major retailers, will expose at least 750,000 people per year to our revolutionary product."
The call can be accessed by dialing (616) 597-8000. Callers will be prompted to enter the Participant Access Code: 1098656#.
For more info: http://sior.realpennies.com
SUPERIOR OIL & GAS COMPANY (OTCBB: SIOR) up 27.78% in morning trading
Superior Oil and Gas Co. operates as an oil and gas exploration and development company. It has interest in undeveloped oil and gas leases, totaling 2,883 acres in Oklahoma and Texas. The company was incorporated as Western States Resources, Inc. in February 1989 and changed its name to Red River Resources, Inc. in March 1997. Later, it changed its name to Superior Oil and Gas Co. in June 1997. Superior Oil and Gas is based in Yukon, Oklahoma.
SIOR News:
February 20 - Superior Oil and Gas Co. Logs Its Gayla No. 1 Well
Superior Oil and Gas Co. (OTCBB: SIOR) has completed the drilling and logging of the Gayla No. I Well located in Logan County, Oklahoma, announced Dan Lloyd, President of Superior. "This well is an offset to our Chickie No.1 Well, which is currently being completed," said Lloyd. "According to our company geologist, the open hole logs were very optimistic and the logs indicated several formations that are potentially productive. We will perforate the first zone of interest today and continue with our completion operations on the other zones as conditions allow," Lloyd said.
For more info: http://vred.realpennies.com
VIRTUAL ED LINK INCORPORATED (OTC: VRED) up 25.00% in morning trading
Virtual Ed Link Inc. responds to the growing need from school campuses (K-12 and higher education institutions) to collect, access, share and disseminate vital information within school districts. The School Safety Management System (SSMS), through VELI, is web-based and can be accessed anywhere. SSMS can be customized for the particular school or college in which it is being implemented. Basic guidelines, rules and procedures, and general notifications are embedded as defaults, or the school can install its own.
VRED News:
February 20 - Virtual Ed Link Wins New York State's CoSer Contract Status
State Funding Available to Schools for VELI's School Safety and Security System
CEO John Bay stated: "Securing this approval is a significant step for both us and schools concerned about bolstering their security measures. Qualifying schools can now easily channel state funds toward establishing the VELI solution at their respective campuses."
South Colonie is one of the school campuses in which the VELI System is in the final project delivery phase. Michael Marcelle, Superintendent of Schools for South Colonie Central School District in Upstate New York, said: "Our confidence in the VELI staff and solution is unlimited. We've found they deliver what they promise!"
Virtual Ed Link has made significant progress since our inception. The demand for VELI's life-saving product continues to grow at an accelerated rate that we did not anticipate. Virtual Ed Link's focus is to establish our SSMS as the standard for school safety. At this time we feel it is prudent to raise our 2008 revenue forecast from $3 million to $4-6 million.
For more info: http://upbs.realpennies.com
UPSTREAM BIOSCIENCES (OTCBB: UPBS) up 9.09% in morning trading
Founded in 2004, Upstream Biosciences is a pioneer in the discovery and development of novel compounds against tropical parasitic diseases and in the development of genetic diagnostics for cancer susceptibility and drug response. Upstream's innovative approach to drug discovery and its proprietary data mining pipeline enable it to apply advanced computational approaches to generating novel drug candidates and to locating and analyzing the genetic variations important to disease progression and drug response. For more information, visit www.upstreambio.com.
UPBS News:
February 20 - Upstream Biosciences Appoints Leading Bioinformatics Expert Dr. Winston Hide to Its Scientific Advisory Board
Dr. Hide's Expertise Spans Bioinformatics, Computational Genomics, Drug Discovery and Tropical Diseases and Includes Distinguished Positions in Academia, the Public Sector and Industry
Upstream Biosciences Inc. (OTCBB: UPBS) announced the appointment of Winston Hide, Ph.D., to its Scientific Advisory Board (SAB). Dr. Hide is a world-renowned bioinformatics expert who is the founder and Director of the South African National Bioinformatics Institute at the University of the Western Cape (UWC) in Cape Town, South Africa. He is Professor of Genomics at UWC and currently serves as Visiting Professor of Bioinformatics at the Harvard University School of Public Health. Dr. Hide's areas of expertise include computational biology and bioinformatics, genomics, tropical diseases and cancer. He has had a distinguished career as a researcher and teacher and also played a major role in creating a series of institutions for advanced biological and medical research in Africa and elsewhere.
As a member of Upstream's SAB, Dr. Hide has agreed to assist the company in the ongoing refinement of its advanced computational drug discovery platform and the development of its library of novel compounds for the treatment of tropical parasitic diseases, including malaria, leishmaniasis and trypanosomiasis, or African sleeping sickness.
"Winston represents a treasure trove of knowledge and insight that are highly relevant to our drug discovery efforts," said Joel L. Bellenson, Chief Executive Officer of Upstream. "He is a world class bioinformatics expert who can understand our unique computational discovery platform at a profound level. He is an African who has devoted a significant portion of his career to building first class scientific institutions in Africa and to discovering better treatments for devastating tropical diseases. His broad research interests include cancer, and our library may contain compounds with potential against malignancies. Winston is also an entrepreneur who has achieved success in private industry. We look forward to his contributions to our efforts to rapidly advance our promising drug candidates for malaria and other tropical diseases." Upstream's computational drug discovery platform has the potential to identify and optimize multiple drug candidates quickly and efficiently. The company currently is conducting preclinical tests on a number of compounds in the hope of treating major tropical diseases. Upstream recently announced preliminary results indicating that its novel structural class of agents is demonstrating promising in vitro activity against malaria. Upstream's compounds have also shown encouraging therapeutic potential in vitro against leishmaniasis and trypanosomiasis. Malaria, leishmaniasis and trypanosomiasis, which are caused by related parasites, are leading sources of disability, death and economic hardship in Africa.
"With our shared commitment to developing solutions for diseases disproportionately affecting the people of Africa and other developing nations, I am delighted to support the Upstream team at this exciting time in the company's development, as its computational discovery platform and library of drug candidates are producing positive preclinical data," said Dr. Hide. "Upstream's strategy of advancing its pipeline by leveraging relationships with a variety of global institutions is congruent with my own approach, and I look forward to supporting its drug discovery and development efforts going forward."
In addition to his roles at UWC and Harvard, Dr. Hide currently leads a pathogen bioinformatics unit of the South African Medical Research Council where he is responsible for the bioinformatics of the Tsetse Fly Genome Project. The tsetse fly carries the pathogen that causes African sleeping sickness. In collaboration with the European 6th Framework Programme, the U.S. Department of Energy, the Brazilian Genome Project and the International Human Genome Consortium, Dr. Hide has developed several systems for disease gene discovery. Collaborating Institutions include Stanford, Harvard, Yale, Oxford, Riken, Cambridge and Tokyo Universities, and the Pasteur Institute.
Dr. Hide founded the African Society for Computational Biology and Bioinformatics and established Africa's first World Health Organization African Regional Training Centre for Bioinformatics, its first National Bioinformatics Network, its first large-scale HIV bioinformatics program and its first accredited graduate program in bioinformatics. He was the first African to be elected to the Board of Directors of the International Society for Computational Biology. Dr. Hide was a Keck Computational Fellow at the Baylor College of Medicine Department of Molecular Genetics and also a Fellow at the Smithsonian National Museum of Natural History in Washington, DC. He was a Director of Genomics at MasPar Computer Corporation in Silicon Valley. Dr. Hide is an International Kerr Programme Fellow of the Ludwig Institute for Cancer Research.
Dr. Hide received a BSc degree from the University College Cardiff, University of Wales and a Ph.D. in molecular genetics from Temple University. He lectures widely and serves as an editorial board member and reviewer for numerous scientific journals. Dr. Hide is the recipient of many honors and awards.
For more info: http://dfns.realpennies.com
DEFENSE INDUSTRIES INTERNATIONAL (OTCBB: DFNS) up 16.67% in morning trading
Defense Industries International, Inc. is a leading manufacturer and global provider of personal military and civilian protective equipment and supplies. Defense Industries' main products include body armor, bomb disposal suits and bullet-resistant vests and jackets; ballistic wall covers, ceramic armor plates and lightweight armor UHMW-PE plates; personal military equipment, battle pouch units and combat harness units; dry storage units, liquid logistics, tents and vehicle covers; winter suits, sleeping bags and backpacks. The Company's manufacturing facilities meet American EQNET and international ISO 9001 standards. The Company has three principal subsidiaries, Export Erez Ltd., Achidatex Nazareth Elite ltd. and Owen Mills in the USA. For additional information, please visit the Company's web site at www.defense-industries.com.
DFNS News:
February 20 - Defense Industries International Announces the Securities and Exchange Commission Has Concluded Its Review of the Company's 2006 Year End and 2007 Quarterly Financial Statements
Defense Industries International, Inc. (OTCBB: DFNS), a leading manufacturer and global provider of personal military and civilian protective equipment and supplies, announced that the Securities and Exchange Commission completed its review of the company's prior filings on Forms 10-KSB and 10-QSB for the year ended December 31, 2006 and the quarters ended March 31 and June 30, 2007 and notified Defense Industries that no additional changes to its financial statements are necessary.
Read our full disclaimer at: http://www.realpennies.com/start.html
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html
Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html
RealPennies .
Telephone: 1-800-940-6559
Matt /at/ realpennies.com
No comments:
Post a Comment